Journal for ImmunoTherapy of Cancer (Nov 2020)
769 CAR T cells undergoing epigenetic reprogramming by low-dose decitabine enhances persistent anti-tumor efficacy in vivo
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2020)